insights_auto
Why is TMCI up 2,05%?
Dive Deeperchevron_right
TMCI:NASDAQ
Treace Medical Concepts, Inc
4,48 $
arrow_upward
+2,05%(+0,090) 1D
5 հոկ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
4,40 $
High
4,54 $
Low
4,24 $
Mkt. cap
291,35 մլն
Avg. vol.
238,13 հզր
Volume
210,72 հզր
52-wk high
7,08 $
52-wk low
1,17 $
EPS
-0,93 $
Beta
1,48
Shares outstanding
65,04 մլն
No. of employees
450
Open
4,40 $
High
4,54 $
Low
4,24 $
Mkt. cap
291,35 մլն
Avg. vol.
238,13 հզր
Volume
210,72 հզր
52-wk high
7,08 $
52-wk low
1,17 $
EPS
-0,93 $
Beta
1,48
Shares outstanding
65,04 մլն
No. of employees
450
News stories
From web sources and news partners
Stock Titan
·
17 րոպե առաջ
Why Small Caps Are Lagging the Nasdaq Record in 2026
24/7 Wall St.
·
37 րոպե առաջ
SPYM Charges Less Than VOO for the Same S&P 500. Its Long-Term Record Tracks Four Different Indexes
The Lufkin Daily News
·
1 ժամ առաջ
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City
The Motley Fool
·
44 րոպե առաջ
Stock Market Today, Oct. 5: Tech Momentum Lifts Nasdaq as Treasury Yields Surge
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc